Background and Aims: Chemotherapy-induced acute and delayed emesis involves the activation of various pathways, with 5-hydroxytryptamine (five-HT; serotonin) playing A serious position within the Original response. Compound P tachykinin NK1 receptor antagonists can lessen emesis induced by disparate